Pfizer Licensing, Development & Alliances
Compound Transfer Program

Pfizer has an extensive pure powder transfer program that encompasses all of our publicly known compounds. We review each request regarding use of our compounds for content, value, and consistency with Pfizer's direction for the requested compound. We routinely enter Compound Transfer Agreements (CTAs) that provide the compound free of charge to a third party to conduct the agreed upon study. We require a manuscript or report of the conclusions to bring closure to the study. Pfizer reserves the right to deny any request that we feel does not advance our compound(s) or add value to human or animal health.

To request a Pfizer pure substance compound please complete this compound request form. This form will provide Pfizer with the information required to issue our CTA. Please attach a full protocol with your request that will be made part of the Statement of Investigation (SOI) The SOI will be the document used to review and approve your submitted study. It needs to be a specific and detailed description of your proposed study. From initial contact to the approved compound(s) arriving at your facility is normally 12 weeks You will receive an auto reply email providing you confirmation of your order with your request number and contact information on how to inquiry about the status of your request.

Donnie W. Owens
Pfizer Compound Transfer Manager
Worldwide Strategic Alliances
Pfizer Inc
MS 8200-30
Eastern Point Road
Groton, CT 06340